Table2_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.XLSX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Table6_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.XLSX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Table8_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.DOCX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Presentation1_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.pdf by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Table3_Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma.XLSX by Pavan Vedula (11984267)

“…Our results suggest a global change in protein processing and regulation that occurs in response to SARS-CoV-2, and the existence of a posttranslational COVID-19 signature that includes an elevation in threonine phosphorylation, a change in glycosylation, and a decrease in arginylation, an emerging posttranslational modification not previously implicated in infectious disease. …”

Single-molecule properties of the Head1/Neck3 chimera. by Sarah Adio (374199)

“…Imperfect head-head coordination is most likely the reason for a higher detachment probability and the decrease in processivity.…”

OVOL1 and OVOL2 induce MET in mesenchymal prostate cancer cells. by Hernan Roca (466557)

“…</p> <p>(I) Schematic: The ZEB1 promoter with potential OVOL2 binding sites (orange triangles) according to the general consensus: 5’-A(A/T) (A/T) (C/A) (T/C)GTTA(T/A). Designed TaqMan primer-pairs are shown as black arrows. …”

Detection of apoptosis using flow cytometry. by Xi Fu (409609)

“…The arginine, homoarginine treatment significantly reduced the apoptosis of GA1 model cells, whereas the leucine and tyrosine treatment led to a slightly decrease in apoptosis that was not statistically significant. …”

Data_Sheet_1_The Association Between Shift Work and Immunological Biomarkers in Nurses.PDF by Bjørn Bjorvatn (35254)

Large-scale analysis by SAGE reveals new mechanisms of oncogene action-4 by Corinne Bresson (73910)

“…The fold repression is represented, corresponding to a decrease of mRNA accumulation in T2ECs expressing the transforming form of v-ErbA (VA) in comparison with T2ECs expressing the non-transforming form of v-ErbA (NTVA). …”

Gas exchange and millet phytomass under organic fertilization and graywater irrigation by José R. I. Silva (12819968)

Comparison of mAB 305-78-7 binding epitopes identified using DXMS and X-ray crystallography. by Alexey V. Gribenko (2183226)

REDUCTION IN KNEE PAIN SYMPTOMS IN ATHLETES USING AN ACUPUNCTURE PROTOCOL by Ana Paula Rehme Siqueira (6043091)

“…All participants reported experiencing a decrease in knee pain after treatment. The affected limbs showed an increase in average strength by 34% and 25% compared to the contralateral limb. …”

Characteristics of the latent classes. by Zhongheng Zhang (552412)

“…Each question was followed by an answer annotated by uppercase letters such as A, B, C, D and E. Annotations: how to assess the effectiveness of aerosol therapy (AssessEffect.How): A: Waveform B: Breathing sound C: Inspection of breathing appearance D: Not assess routinely E: others Filter exchange frequency (FilterExchange.frq) A: Every time after nebulization B: Once daily C: Twice a week D: Once a week E: More than once a week Nebulizer position for Metered dose nebulization (FixedDose.connector) A: Inspiratory limb near Y-piece B: Humidifier proximal to ventilator C: Humidifier proximal to patient D: others Use of holding chambers / spacers for metered dose nebulization (FixedDose.Container) A: yes B: no C: never use Use of aerosol therapy for invasive mechanical ventilation (IMV.nebulization.flg) A: Yes Type of jet nebulizer (JetNebulizer.type) A: external gas source B: external nebulizer pump C: nebulizer within ventilator D: others Nebulizer position for small-volume nebulizer (LowDose.connector) A: Inspiratory limb near Y-piece B: Humidifier proximal to ventilator C: Humidifier proximal to patient D: others Change of MV setting during nebulization (MVparameter.onNebu) A: Never change B: Increase PEEP C: Decrease inspiratory flow D: Use constant inspiratory flow E: Increase inspiratory time F: Use inspiratory pause G: Increase tidal volume H: Stop heated humidifier I: Place filter on expiratory circuit J: Sedation to avoid dyssynchrony K: Use base flow rate L: Others Type of nebulization drug (Nebu.Drug) A: bronchodilators B: antibiotics C: mucolytic agent D: topical steroids E: systemic steroids F: others Type of nebulizer (Nebulizer.type) A: ultrasonic nebulizer B: jet nebulizer C: vibrating mesh nebulizer D: metered dose E: others Use of protocol for aerosol therapy (NebuProtocal.flg) A: yes Use of nebulization during noninvasive mechanical ventilation (NIMV.nebulization.flg) A: yes PEEP level during aerosol therapy (PEEP.onNebu) A: 0 B: 1–5 C: 6–10 D: >10 E: PEEP not changed Model of ventilator setting during aerosol therapy (SpecialNebu) A: Pressure control B: Pressure support C: volume control D: SIMV E: High-frequency ventilation F: others.…”

<i>Bmp2</i> upregulation in senescence. by Atsushi Kaneda (198186)

“…(<i>E</i>) Western blot analysis showing increased level of Smad1/5/8 phosphorylation in RasV12 cells, and decrease in <i>Bmp2</i>-knocked-down RasV12 cells. …”

Supporting data for "The Role of Mitochondrial Translocator Protein in Chronic Kidney Disease" by Yuchen Feng (11263161)

S1 Data - by Maria Luisa Arruda Correia (16455693)

“…</p><p>Materials and methods</p><p>This is a prospective study with pregnant women undergoing outpatient follow-up and hospitalized in a ward at Instituto Fernandes Figueira/Fiocruz, between August 2021 to August 2022, during the SARS-CoV-2 pandemic. …”

Flow diagram. by Maria Luisa Arruda Correia (16455693)

“…</p><p>Materials and methods</p><p>This is a prospective study with pregnant women undergoing outpatient follow-up and hospitalized in a ward at Instituto Fernandes Figueira/Fiocruz, between August 2021 to August 2022, during the SARS-CoV-2 pandemic. …”

Flow chamber adhesion assay and changes in cell adhesion strength. by Daniel J. Modulevsky (307313)

Dataset Fluorishing by Concetta Pirrone (17472111)